Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2026, Fuji Pharma has already paid €0.12 in dividends. The last payout was in June.

Financials

In the last quarter, Fuji Pharma had revenue of €95.28m and net profit of €5.66m
(EUR) September 2026
YoY
Revenue 95.28m 12.40%
Gross profit 37.28m 7.73%
Net profit 5.66m 15.91%
EBITDA 5.38m 64.47%

Fundamentals

Metric Value
Market capitalization
€275.92m
Number of shares
26.12m
52-week high/low
€14.56 - €9.42
Dividend yield
2.49%
Dividends TTM
€0.26
Beta
0.34
P/E ratio
16.85
PEG ratio
-1.63
P/B ratio
0.92
P/S ratio
0.78

Company profile

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women; in vitro diagnostics, acute medical care products, and curative medicines; and information regarding pharmaceuticals and health. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.

Name
Fuji Pharma
CEO
Shuhei Morita
Headquarters Tokyo, ty
Japan
Website
IPO
22/02/2010
Employees 1,760

Ticker symbols

Exchange Symbol
Japan Exchange Group
4554.T
Frankfurt
FUP.F
Düsseldorf
FUP.DU
🍪

Parqet  uses cookies. Learn more